Michèle Morin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Michèle Morin has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- France Légaré
Department of Family Medicine and Emergency Medicine, Université Laval, Quebec, Quebec, Canada
6 shared publications - Isabelle Violet
Ministère de la santé et des services sociaux du Québec, Quebec, CA
4 shared publications - Julie Gilbert
Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale, Quebec, CA
4 shared publications - Nancy Chénard
Centre intégré de santé et de services sociaux de Chaudière-Appalaches, Lévis, CA
4 shared publications - Nouha Ben Gaied
Federation of Quebec Alzheimer Societies, Montreal, QC Canada
4 shared publications - Patrick Michel Archambault
Université Laval
4 shared publications
Latest Publications
- Open Access
Serious Illness Conversations in Older Patients at High Risk of Mortality in Primary Care During the COVID-19 Pandemic: A Quasi-Experimental Study
Purpose: Serious Illness Conversations (SICs) are essential to delivering person-centered care for older adults with chronic conditions, but are rarely integrated into routine primary care. To address this gap, we compared the effectiveness of a structured training strategy versus passive dissemination of educational materials on SIC documentation rates during the COVID-19 pandemic. Methods: A quasi-experimental study across 13 primary care clinics in Quebec, Canada. Five clinics received structured team-based Serious Illness Care Program training (intervention group) with a provincially disseminated SIC toolkit and eight received the toolkit only (control group). The primary outcome was the proportion of patients with a documented SIC across three time periods (Period 1, pre pandemic; Period 2, pandemic initial wave; and Period 3, post dissemination of SIC toolkit). We used generalized estimating equations (GEE). Results: Across 13 clinics, 2,368 eligible patients (mean age 75.8 years ( SD = 7.5), 54% female, with a mean Charlson Comorbidity Index of 4.88 ( SD = 2)) accounted for 19,134 clinical visits, 49.5% in person and 49.6% virtually. SIC documentation rates were 3.3% (control) and 3.4% (intervention) in Period 1, 9.3% and 4.3% in Period 2, and 6.4% and 4.8% in Period 3, respectively. There was no statistically significant improvement to SIC documentation in the intervention group at Period 2 nor Period 3. Conclusion: Structured training was not more effective than passive dissemination for SIC documentation. Educational interventions must be supported by structural changes, workflow integration, and organizational leadership. Multi-level implementation strategies are needed to embed SICs sustainably into primary care.
Open AccessSerious Illness Conversations in Older Patients at High Risk of Mortality in Primary Care During the COVID-19 Pandemic: A Quasi-Experimental Study
Purpose: Serious Illness Conversations (SICs) are essential to delivering person-centered care for older adults with chronic conditions, but are rarely integrated into routine primary care. To address this gap, we compared the effectiveness of a structured training strategy versus passive dissemination of educational materials on SIC documentation rates during the COVID-19 pandemic. Methods: A quasi-experimental study across 13 primary care clinics in Quebec, Canada. Five clinics received structured team-based Serious Illness Care Program training (intervention group) with a provincially disseminated SIC toolkit and eight received the toolkit only (control group). The primary outcome was the proportion of patients with a documented SIC across three time periods (Period 1, pre pandemic; Period 2, pandemic initial wave; and Period 3, post dissemination of SIC toolkit). We used generalized estimating equations (GEE). Results: Across 13 clinics, 2,368 eligible patients (mean age 75.8 years ( SD = 7.5), 54% female, with a mean Charlson Comorbidity Index of 4.88 ( SD = 2)) accounted for 19,134 clinical visits, 49.5% in person and 49.6% virtually. SIC documentation rates were 3.3% (control) and 3.4% (intervention) in Period 1, 9.3% and 4.3% in Period 2, and 6.4% and 4.8% in Period 3, respectively. There was no statistically significant improvement to SIC documentation in the intervention group at Period 2 nor Period 3. Conclusion: Structured training was not more effective than passive dissemination for SIC documentation. Educational interventions must be supported by structural changes, workflow integration, and organizational leadership. Multi-level implementation strategies are needed to embed SICs sustainably into primary care.
- Open Access
- 9 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Support for Older Adults Receiving Home Care and their Caregivers Making Difficult Decisions (ENGAGE): a Multi-Method Study to Select, Update and Disseminate Relevant Patient Decision Aids (Preprint)
BACKGROUND Older adults receiving home care often face complex health decisions requiring a balance between medical evidence and personal values. Patient decision aids (PDAs) are evidence-based tools that can help older adults receiving home care make informed, value-congruent choices. OBJECTIVE To engage interest‐holders, including older adults, in choosing the most relevant existing PDAs for older adults receiving home care, update them, culturally adapt them and disseminate them in preparation for scaling them across Quebec’s home care system. METHODS We conducted a multi-method consensus study under the guidance of an interdisciplinary steering committee composed of older adults, caregivers, community representatives, clinicians, decision-makers and researchers. In phase 1, we listed the PDAs relevant to older adults receiving home care identified in an earlier systematic review. The steering committee made an initial selection of the identified PDAs based on evidence on their scalability, quality and the difficulty of the decision. In phase 2, an eDelphi panel assessed the importance of the PDAs based on panellists’ perceptions of the frequency of the decision addressed, its difficulty, the place of values and preferences in the decision addressed, and the feasibility of an update. PDAs meeting a 75% importance threshold advanced to the second round, when the same criteria were applied. The PDAs were ranked in order of importance, and the steering committee selected the final PDA to update. In phase 3, the steering committee performed a rapid review to update the evidence. For the rapid review, we searched MEDLINE and CENTRAL for relevant systematic reviews and summarized results. We integrated this new evidence into the new PDA, culturally adapted it to the Quebec context, and planned its dissemination. RESULTS The systematic review identified 33 PDAs originating in North America, Europe and Australia and the Steering Committee selected 10 based on their scalability, quality and decision difficulty. Sixty panellists with a wide variety of expertise for the two-round eDelphi process were recruited through snowball sampling, and 44 (73%) completed at least one round. Six of the 10 PDAs advanced to the second round. The final PDA selected addressed quality-of-life decisions for older adults living with neurocognitive disorders. The rapid review of reviews of interventions relevant to these decisions identified 5 additional interventions that were integrated into the selected PDA for a total of 10 decision options. The PDA was culturally adapted to Quebec. Paper and online versions were published in preparation for large-scale implementation across the province of Quebec. CONCLUSIONS This structured and participatory consensus process prepares the ground for scaling an adapted and updated PDA to facilitate shared decision-making with older adults in Quebec’s home care context. INTERNATIONAL REGISTERED REPORT RR2-10.2196/53150
- 9 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessSupport for Older Adults Receiving Home Care and their Caregivers Making Difficult Decisions (ENGAGE): a Multi-Method Study to Select, Update and Disseminate Relevant Patient Decision Aids (Preprint)
BACKGROUND Older adults receiving home care often face complex health decisions requiring a balance between medical evidence and personal values. Patient decision aids (PDAs) are evidence-based tools that can help older adults receiving home care make informed, value-congruent choices. OBJECTIVE To engage interest‐holders, including older adults, in choosing the most relevant existing PDAs for older adults receiving home care, update them, culturally adapt them and disseminate them in preparation for scaling them across Quebec’s home care system. METHODS We conducted a multi-method consensus study under the guidance of an interdisciplinary steering committee composed of older adults, caregivers, community representatives, clinicians, decision-makers and researchers. In phase 1, we listed the PDAs relevant to older adults receiving home care identified in an earlier systematic review. The steering committee made an initial selection of the identified PDAs based on evidence on their scalability, quality and the difficulty of the decision. In phase 2, an eDelphi panel assessed the importance of the PDAs based on panellists’ perceptions of the frequency of the decision addressed, its difficulty, the place of values and preferences in the decision addressed, and the feasibility of an update. PDAs meeting a 75% importance threshold advanced to the second round, when the same criteria were applied. The PDAs were ranked in order of importance, and the steering committee selected the final PDA to update. In phase 3, the steering committee performed a rapid review to update the evidence. For the rapid review, we searched MEDLINE and CENTRAL for relevant systematic reviews and summarized results. We integrated this new evidence into the new PDA, culturally adapted it to the Quebec context, and planned its dissemination. RESULTS The systematic review identified 33 PDAs originating in North America, Europe and Australia and the Steering Committee selected 10 based on their scalability, quality and decision difficulty. Sixty panellists with a wide variety of expertise for the two-round eDelphi process were recruited through snowball sampling, and 44 (73%) completed at least one round. Six of the 10 PDAs advanced to the second round. The final PDA selected addressed quality-of-life decisions for older adults living with neurocognitive disorders. The rapid review of reviews of interventions relevant to these decisions identified 5 additional interventions that were integrated into the selected PDA for a total of 10 decision options. The PDA was culturally adapted to Quebec. Paper and online versions were published in preparation for large-scale implementation across the province of Quebec. CONCLUSIONS This structured and participatory consensus process prepares the ground for scaling an adapted and updated PDA to facilitate shared decision-making with older adults in Quebec’s home care context. INTERNATIONAL REGISTERED REPORT RR2-10.2196/53150
- Open Access
- 23 February 2026
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 66 (3) , 103053
Pharmacist-led interventions to optimize the pharmacotherapy of older adults under evaluation for or living with a neurocognitive disorder in the community: A quasi-experimental study
- 23 February 2026
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 66 (3) , 103053
Open AccessPharmacist-led interventions to optimize the pharmacotherapy of older adults under evaluation for or living with a neurocognitive disorder in the community: A quasi-experimental study
- 1 January 2024
- Published by Consortium Erudit in Cahiers francophones de soins palliatifs
- Vol. 24 (2) , 69-79
Développement d’un cadre d’intervention clinique soutenant le processus associé aux niveaux de soins dans une organisation à mission populationnelle
Le processus de niveau de soins vise à guider le recours à des interventions de maintien des fonctions vitales. Les besoins d’information et les préférences de soins d’une personne évoluent au cours de sa vie. De plus, les interventions entourant ce processus se déroulent dans divers milieux de soins à différents moments de la trajectoire de soins et nécessitent une approche interdisciplinaire. Il s’agit donc d’une pratique complexe qui devrait être implantée et pérennisée par des personnes désignées comme responsables de soutenir les équipes interdisciplinaires. Or, il n’existait pas de cadre d’intervention clinique adapté au contexte du Québec permettant d’offrir des balises aux personnes responsables et aux équipes interdisciplinaires. Nous avons développé un cadre d’intervention clinique adapté aux organisations québécoises à mission populationnelle en suivant un processus séquentiel en quatre étapes : 1) portrait de la situation actuelle des niveaux de soins dans l’organisation ; 2) recherche ciblée dans la littérature scientifique et grise ; 3) développement d’un prototype ; et 4) codéveloppement et validation du cadre final. Ce cadre décrit six processus de niveaux de soins adaptés à l’état de santé de la personne, de la santé à la fin de vie, en passant par la maladie grave soudaine. Il peut être utilisé tel quel ou adapté selon les besoins des organisations. Il peut aussi guider l’implantation d’autres pratiques complexes connexes, telles que l’harmonisation des approches palliatives et curatives. Cet article décrit le processus de développement du cadre d’intervention clinique ainsi que le cadre lui-même.
- 1 January 2024
- Published by Consortium Erudit in Cahiers francophones de soins palliatifs
- Vol. 24 (2) , 69-79
Développement d’un cadre d’intervention clinique soutenant le processus associé aux niveaux de soins dans une organisation à mission populationnelle
Le processus de niveau de soins vise à guider le recours à des interventions de maintien des fonctions vitales. Les besoins d’information et les préférences de soins d’une personne évoluent au cours de sa vie. De plus, les interventions entourant ce processus se déroulent dans divers milieux de soins à différents moments de la trajectoire de soins et nécessitent une approche interdisciplinaire. Il s’agit donc d’une pratique complexe qui devrait être implantée et pérennisée par des personnes désignées comme responsables de soutenir les équipes interdisciplinaires. Or, il n’existait pas de cadre d’intervention clinique adapté au contexte du Québec permettant d’offrir des balises aux personnes responsables et aux équipes interdisciplinaires. Nous avons développé un cadre d’intervention clinique adapté aux organisations québécoises à mission populationnelle en suivant un processus séquentiel en quatre étapes : 1) portrait de la situation actuelle des niveaux de soins dans l’organisation ; 2) recherche ciblée dans la littérature scientifique et grise ; 3) développement d’un prototype ; et 4) codéveloppement et validation du cadre final. Ce cadre décrit six processus de niveaux de soins adaptés à l’état de santé de la personne, de la santé à la fin de vie, en passant par la maladie grave soudaine. Il peut être utilisé tel quel ou adapté selon les besoins des organisations. Il peut aussi guider l’implantation d’autres pratiques complexes connexes, telles que l’harmonisation des approches palliatives et curatives. Cet article décrit le processus de développement du cadre d’intervention clinique ainsi que le cadre lui-même.
- Open Access
- 20 November 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e53150
Engagement of Older Adults Receiving Home Care Services and Their Caregivers in Health Decisions in Partnership With Clinical Teams: Protocol for a Multimethod Study to Prioritize and Culturally Adapt Decision Aids for Home Care
Background: Older adults (people aged 65 years and older) face many difficult decisions. Patient decision aids (PtDAs) can help them and their families make informed value-congruent decisions. Some PtDAs have been developed for the home care context, but little is known about scaling them for use with older adults in a different culture. Objective: This study aims to (1) assess the scalability of existing PtDAs for older adults in the home care context; (2) prioritize those that best match the decisional needs of older adults in home care; and (3) culturally adapt the prioritized PtDAs so they can be scaled successfully to the Quebec health care system. Methods: This multimethod study includes 3 phases. All phases will be overseen by a steering committee of older adults, caregivers, health professionals, decision makers, community organization representatives, and researchers with the needed expertise. In phase 1, we will use the Innovation Scalability Self-administered Questionnaire, a validated scalability self-assessment tool, to assess the scalability of 33 PtDAs previously identified in a systematic review. Based on their scalability, their quality (based on the International Patient Decision Aids Standards), and the importance of the decision point, we will retain approximately a third of these. In phase 2, we will conduct a 2-round web-based Delphi to prioritize the PtDAs selected in phase 1. Using a snowball recruitment strategy, we aim to recruit 60 Delphi participants in the province of Quebec, including older adults, caregivers, health professionals, decision makers involved in home care services, and PtDA experts. In the first round, we will ask participants to rate the importance of several PtDA decision points according to various criteria such as prevalence and difficulty on a 5-point Likert scale (1=not important to 5=very important). Approximately 6 of the highest-rated PtDAs will be retained for presentation in the second round, and we will select up to 3 PtDAs judged as having the highest priority for cultural adaptation. In phase 3, using the Chenel framework and user-centered design methods, we will update and adapt the PtDAs to the Quebec health care system and integrate these PtDAs into an interprofessional shared decision-making training program for home care teams. The adapted PtDAs will respect the International Patient Decision Aids Standards criteria. Results: This study was funded in March 2022 by the Canadian Institutes of Health Research. Data collection for the web-based Delphi began in October 2023. Results are expected to be published in May 2024. Conclusions: This project will provide relevant and culturally appropriate decision support tools for older adults making difficult decisions and their home care teams that will be ready for scaling across the province of Quebec. International Registered Report Identifier (IRRID): PRR1-10.2196/53150
- 20 November 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12 (1) , e53150
Open AccessEngagement of Older Adults Receiving Home Care Services and Their Caregivers in Health Decisions in Partnership With Clinical Teams: Protocol for a Multimethod Study to Prioritize and Culturally Adapt Decision Aids for Home Care
Background: Older adults (people aged 65 years and older) face many difficult decisions. Patient decision aids (PtDAs) can help them and their families make informed value-congruent decisions. Some PtDAs have been developed for the home care context, but little is known about scaling them for use with older adults in a different culture. Objective: This study aims to (1) assess the scalability of existing PtDAs for older adults in the home care context; (2) prioritize those that best match the decisional needs of older adults in home care; and (3) culturally adapt the prioritized PtDAs so they can be scaled successfully to the Quebec health care system. Methods: This multimethod study includes 3 phases. All phases will be overseen by a steering committee of older adults, caregivers, health professionals, decision makers, community organization representatives, and researchers with the needed expertise. In phase 1, we will use the Innovation Scalability Self-administered Questionnaire, a validated scalability self-assessment tool, to assess the scalability of 33 PtDAs previously identified in a systematic review. Based on their scalability, their quality (based on the International Patient Decision Aids Standards), and the importance of the decision point, we will retain approximately a third of these. In phase 2, we will conduct a 2-round web-based Delphi to prioritize the PtDAs selected in phase 1. Using a snowball recruitment strategy, we aim to recruit 60 Delphi participants in the province of Quebec, including older adults, caregivers, health professionals, decision makers involved in home care services, and PtDA experts. In the first round, we will ask participants to rate the importance of several PtDA decision points according to various criteria such as prevalence and difficulty on a 5-point Likert scale (1=not important to 5=very important). Approximately 6 of the highest-rated PtDAs will be retained for presentation in the second round, and we will select up to 3 PtDAs judged as having the highest priority for cultural adaptation. In phase 3, using the Chenel framework and user-centered design methods, we will update and adapt the PtDAs to the Quebec health care system and integrate these PtDAs into an interprofessional shared decision-making training program for home care teams. The adapted PtDAs will respect the International Patient Decision Aids Standards criteria. Results: This study was funded in March 2022 by the Canadian Institutes of Health Research. Data collection for the web-based Delphi began in October 2023. Results are expected to be published in May 2024. Conclusions: This project will provide relevant and culturally appropriate decision support tools for older adults making difficult decisions and their home care teams that will be ready for scaling across the province of Quebec. International Registered Report Identifier (IRRID): PRR1-10.2196/53150
- Open Access
- 27 September 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Engagement of Older Adults Receiving Home Care Services and Their Caregivers in Health Decisions in Partnership With Clinical Teams: Protocol for a Multimethod Study to Prioritize and Culturally Adapt Decision Aids for Home Care (Preprint)
BACKGROUND Older adults (people aged 65 years and older) face many difficult decisions. Patient decision aids (PtDAs) can help them and their families make informed value-congruent decisions. Some PtDAs have been developed for the home care context, but little is known about scaling them for use with older adults in a different culture. OBJECTIVE This study aims to (1) assess the scalability of existing PtDAs for older adults in the home care context; (2) prioritize those that best match the decisional needs of older adults in home care; and (3) culturally adapt the prioritized PtDAs so they can be scaled successfully to the Quebec health care system. METHODS This multimethod study includes 3 phases. All phases will be overseen by a steering committee of older adults, caregivers, health professionals, decision makers, community organization representatives, and researchers with the needed expertise. In phase 1, we will use the Innovation Scalability Self-administered Questionnaire, a validated scalability self-assessment tool, to assess the scalability of 33 PtDAs previously identified in a systematic review. Based on their scalability, their quality (based on the International Patient Decision Aids Standards), and the importance of the decision point, we will retain approximately a third of these. In phase 2, we will conduct a 2-round web-based Delphi to prioritize the PtDAs selected in phase 1. Using a snowball recruitment strategy, we aim to recruit 60 Delphi participants in the province of Quebec, including older adults, caregivers, health professionals, decision makers involved in home care services, and PtDA experts. In the first round, we will ask participants to rate the importance of several PtDA decision points according to various criteria such as prevalence and difficulty on a 5-point Likert scale (1=not important to 5=very important). Approximately 6 of the highest-rated PtDAs will be retained for presentation in the second round, and we will select up to 3 PtDAs judged as having the highest priority for cultural adaptation. In phase 3, using the Chenel framework and user-centered design methods, we will update and adapt the PtDAs to the Quebec health care system and integrate these PtDAs into an interprofessional shared decision-making training program for home care teams. The adapted PtDAs will respect the International Patient Decision Aids Standards criteria. RESULTS This study was funded in March 2022 by the Canadian Institutes of Health Research. Data collection for the web-based Delphi began in October 2023. Results are expected to be published in May 2024. CONCLUSIONS This project will provide relevant and culturally appropriate decision support tools for older adults making difficult decisions and their home care teams that will be ready for scaling across the province of Quebec. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/53150
- 27 September 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEngagement of Older Adults Receiving Home Care Services and Their Caregivers in Health Decisions in Partnership With Clinical Teams: Protocol for a Multimethod Study to Prioritize and Culturally Adapt Decision Aids for Home Care (Preprint)
BACKGROUND Older adults (people aged 65 years and older) face many difficult decisions. Patient decision aids (PtDAs) can help them and their families make informed value-congruent decisions. Some PtDAs have been developed for the home care context, but little is known about scaling them for use with older adults in a different culture. OBJECTIVE This study aims to (1) assess the scalability of existing PtDAs for older adults in the home care context; (2) prioritize those that best match the decisional needs of older adults in home care; and (3) culturally adapt the prioritized PtDAs so they can be scaled successfully to the Quebec health care system. METHODS This multimethod study includes 3 phases. All phases will be overseen by a steering committee of older adults, caregivers, health professionals, decision makers, community organization representatives, and researchers with the needed expertise. In phase 1, we will use the Innovation Scalability Self-administered Questionnaire, a validated scalability self-assessment tool, to assess the scalability of 33 PtDAs previously identified in a systematic review. Based on their scalability, their quality (based on the International Patient Decision Aids Standards), and the importance of the decision point, we will retain approximately a third of these. In phase 2, we will conduct a 2-round web-based Delphi to prioritize the PtDAs selected in phase 1. Using a snowball recruitment strategy, we aim to recruit 60 Delphi participants in the province of Quebec, including older adults, caregivers, health professionals, decision makers involved in home care services, and PtDA experts. In the first round, we will ask participants to rate the importance of several PtDA decision points according to various criteria such as prevalence and difficulty on a 5-point Likert scale (1=not important to 5=very important). Approximately 6 of the highest-rated PtDAs will be retained for presentation in the second round, and we will select up to 3 PtDAs judged as having the highest priority for cultural adaptation. In phase 3, using the Chenel framework and user-centered design methods, we will update and adapt the PtDAs to the Quebec health care system and integrate these PtDAs into an interprofessional shared decision-making training program for home care teams. The adapted PtDAs will respect the International Patient Decision Aids Standards criteria. RESULTS This study was funded in March 2022 by the Canadian Institutes of Health Research. Data collection for the web-based Delphi began in October 2023. Results are expected to be published in May 2024. CONCLUSIONS This project will provide relevant and culturally appropriate decision support tools for older adults making difficult decisions and their home care teams that will be ready for scaling across the province of Quebec. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/53150
- Open Access
- 11 June 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Participation of elderly rural citizens in the Living Lab MOSAIC: Protocol for a longitudinal mixed-method study (Preprint)
BACKGROUND The third generation of living labs could strengthen innovation and the development of broad social effects. Since August 2022, the rural areas of Chaudiere-Appalaches in Quebec, Canada, have been the site of the living lab MOSAIC. Collaborators involved in this living lab include four stakeholders: seniors and their families, representatives of the community, representatives of service providers, researchers. A facilitating team organizes the daily life around the living lab. The success of MOSAIC depends on the involvement of rural elderly in the co-creation, implementation, and sustainability of social innovations. Little is known on how to facilitate the participation of rural elderly in living labs. OBJECTIVE Our objectives are to offer a better understanding of the participation of rural elderly in the development of an intersectoral rural living lab, to explore the enablers to and challengers of older citizens' full participation in the living lab process, and the adaptations put in place to facilitate their participation. METHODS This is a longitudinal mixed-methods study. We will use scientific methods to make sense of diverse sources of secondary and primary data. We will also conduct semi-structured individual interviews at the end of years 1 and 2 and lengthwise observation. Participants will be the collaborators already involved in MOSAIC as well as the facilitating team. RESULTS This study will lead to new findings on the experience of rural seniors participating in a living lab. Additionally, this project will enhance knowledge of the human dynamics involved in establishing a living lab project with elderly rural citizens as well as its implications for epistemology, methodology, and ethics. CONCLUSIONS Participation of end-users, often rural lay persons, are the terms and conditions of a lot of research and development methods increasingly regarded as valuable. This study will result in fresh insights and cutting-edge knowledge on the challenges faced while co-creating and implementing social innovations with the elderly.
- 11 June 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessParticipation of elderly rural citizens in the Living Lab MOSAIC: Protocol for a longitudinal mixed-method study (Preprint)
BACKGROUND The third generation of living labs could strengthen innovation and the development of broad social effects. Since August 2022, the rural areas of Chaudiere-Appalaches in Quebec, Canada, have been the site of the living lab MOSAIC. Collaborators involved in this living lab include four stakeholders: seniors and their families, representatives of the community, representatives of service providers, researchers. A facilitating team organizes the daily life around the living lab. The success of MOSAIC depends on the involvement of rural elderly in the co-creation, implementation, and sustainability of social innovations. Little is known on how to facilitate the participation of rural elderly in living labs. OBJECTIVE Our objectives are to offer a better understanding of the participation of rural elderly in the development of an intersectoral rural living lab, to explore the enablers to and challengers of older citizens' full participation in the living lab process, and the adaptations put in place to facilitate their participation. METHODS This is a longitudinal mixed-methods study. We will use scientific methods to make sense of diverse sources of secondary and primary data. We will also conduct semi-structured individual interviews at the end of years 1 and 2 and lengthwise observation. Participants will be the collaborators already involved in MOSAIC as well as the facilitating team. RESULTS This study will lead to new findings on the experience of rural seniors participating in a living lab. Additionally, this project will enhance knowledge of the human dynamics involved in establishing a living lab project with elderly rural citizens as well as its implications for epistemology, methodology, and ethics. CONCLUSIONS Participation of end-users, often rural lay persons, are the terms and conditions of a lot of research and development methods increasingly regarded as valuable. This study will result in fresh insights and cutting-edge knowledge on the challenges faced while co-creating and implementing social innovations with the elderly.
- Open Access
- 17 November 2022
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 11 (11) , e42577
Reorganizing Pharmaceutical Care in Family Medicine Groups for Older Adults With or at Risk of Major Neurocognitive Disorders: Protocol for a Mixed Methods Study
Background: The latest global figures show that 55 million persons lived with major neurocognitive disorders (MNCDs) worldwide in 2021. In Quebec, Canada, most of these older adults are cared for by family physicians in interdisciplinary primary care clinics such as family medicine groups (FMG). When a person has a MNCD, taking potentially inappropriate medications or polypharmacy (5 different medications or more) increases their vulnerability to serious adverse events. With the recent arrival of pharmacists working in FMGs and their expanded scope of practice and autonomy, new possibilities for optimizing older adults’ pharmacotherapy are opening. Objective: This project aims to evaluate the impact of involving these pharmacists in the care trajectory of older adults living with MNCD, in an interdisciplinary collaboration with the FMG team, as well as home care nurses and physicians. Pharmacists will provide medication reviews, interventions, and recommendations to improve the pharmacotherapy and support offered to these patients and their caregivers. Methods: This 2-step mixed methods study will include a quasi-experimental controlled trial (step 1) and semistructured interviews (step 2). Older adults undergoing cognitive assessment, recently diagnosed with MNCD, or receiving care for this at home will be identified and recruited in FMGs in 2 Quebec regions. FMGs implementing the intervention will involve pharmacists in these patients’ care trajectory. Training and regular mentoring will be offered to these FMGs, especially to pharmacists. In control FMGs, no FMG pharmacist will be involved with these patients, and usual care will be provided. Results: Medication use (including appropriateness) and burden, satisfaction of care received, and quality of life will be assessed at study beginning and after 6 months of follow-up and compared between groups. At the end of the intervention study, we will conduct semistructured interviews with FMG care team members (pharmacists, nurses, and physicians) who have experienced the intervention. We will ask about the feasibility of integrating the intervention into practice and their satisfaction with and their perception of the intervention’s impacts for older adults and their families. We will assess the effect of improved pharmaceutical care for older adults with or at risk of MNCDs through the involvement of FMG pharmacists and a reorganization of pharmaceutical care. Conclusions: The inclusion of pharmacists in interdisciplinary care teams is recent and rising, strengthened by more substantial pharmacist practice roles. Results will inform the processes required to successfully involve pharmacists and implement developed tools and procedures transposable to other care settings to improve patient care. Trial Registration: ClinicalTrials.gov NCT04889794; https://clinicaltrials.gov/ct2/show/NCT04889794 International Registered Report Identifier (IRRID): DERR1-10.2196/42577
- 17 November 2022
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 11 (11) , e42577
Open AccessReorganizing Pharmaceutical Care in Family Medicine Groups for Older Adults With or at Risk of Major Neurocognitive Disorders: Protocol for a Mixed Methods Study
Background: The latest global figures show that 55 million persons lived with major neurocognitive disorders (MNCDs) worldwide in 2021. In Quebec, Canada, most of these older adults are cared for by family physicians in interdisciplinary primary care clinics such as family medicine groups (FMG). When a person has a MNCD, taking potentially inappropriate medications or polypharmacy (5 different medications or more) increases their vulnerability to serious adverse events. With the recent arrival of pharmacists working in FMGs and their expanded scope of practice and autonomy, new possibilities for optimizing older adults’ pharmacotherapy are opening. Objective: This project aims to evaluate the impact of involving these pharmacists in the care trajectory of older adults living with MNCD, in an interdisciplinary collaboration with the FMG team, as well as home care nurses and physicians. Pharmacists will provide medication reviews, interventions, and recommendations to improve the pharmacotherapy and support offered to these patients and their caregivers. Methods: This 2-step mixed methods study will include a quasi-experimental controlled trial (step 1) and semistructured interviews (step 2). Older adults undergoing cognitive assessment, recently diagnosed with MNCD, or receiving care for this at home will be identified and recruited in FMGs in 2 Quebec regions. FMGs implementing the intervention will involve pharmacists in these patients’ care trajectory. Training and regular mentoring will be offered to these FMGs, especially to pharmacists. In control FMGs, no FMG pharmacist will be involved with these patients, and usual care will be provided. Results: Medication use (including appropriateness) and burden, satisfaction of care received, and quality of life will be assessed at study beginning and after 6 months of follow-up and compared between groups. At the end of the intervention study, we will conduct semistructured interviews with FMG care team members (pharmacists, nurses, and physicians) who have experienced the intervention. We will ask about the feasibility of integrating the intervention into practice and their satisfaction with and their perception of the intervention’s impacts for older adults and their families. We will assess the effect of improved pharmaceutical care for older adults with or at risk of MNCDs through the involvement of FMG pharmacists and a reorganization of pharmaceutical care. Conclusions: The inclusion of pharmacists in interdisciplinary care teams is recent and rising, strengthened by more substantial pharmacist practice roles. Results will inform the processes required to successfully involve pharmacists and implement developed tools and procedures transposable to other care settings to improve patient care. Trial Registration: ClinicalTrials.gov NCT04889794; https://clinicaltrials.gov/ct2/show/NCT04889794 International Registered Report Identifier (IRRID): DERR1-10.2196/42577
- Open Access
- 9 September 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Reorganizing pharmaceutical care in family medicine groups for seniors with or at risk of major neurocognitive disorders: protocol for a mixed-methods study (Preprint)
BACKGROUND The latest global figures show that 55 million persons lived with major neurocognitive disorders (MNCDs) worldwide in 2021. In Quebec, Canada, most of these seniors are cared for by family physicians in interdisciplinary primary care clinics such as family medicine groups (FMG). When a person suffers from a MNCD, taking potentially inappropriate medications or polypharmacy (five different medications or more) increases their vulnerability to serious adverse events. With the recent arrival of pharmacists working in FMGs and their expanded scope of practice and autonomy, new possibilities for optimizing seniors' pharmacotherapy are opening. OBJECTIVE This project aims to evaluate the impact of involving these pharmacists in the care trajectory of older adults living with MNCD, in an interdisciplinary collaboration with the FMG team, as well as home care nurses and physicians. Pharmacists will provide medication reviews, interventions, and recommendations to improve the pharmacotherapy and education provided to these patients and their caregivers. METHODS This 2-step mixed methods study will include a quasi-experimental controlled trial (step 1) and semi-structured interviews (step 2). Seniors undergoing cognitive assessment, recently diagnosed with MNCD or receiving care for this at home, will be identified and recruited in FMGs in two Quebec regions. FMGs implementing the intervention will involve pharmacists in these patients’ care trajectory. Training and regular mentoring will be offered to these FMGs, especially to pharmacists. In control FMGs, no FMG pharmacist will be involved with these patients, and usual care will be provided. RESULTS Medication use (including appropriateness) and burden, satisfaction of care received, and quality of life will be assessed at study beginning and after six months of follow-up and compared between groups. At the end of the intervention study, we will conduct semi-structured interviews with FMG care team members (pharmacists, nurses, physicians) who have experienced the intervention. We will ask about the feasibility of integrating the intervention into practice, their satisfaction with and their perception of the intervention impacts for seniors and their families. We will assess the effect of improved pharmaceutical care for seniors with or at risk of MNCDs through the involvement of FMG pharmacists and a reorganization of pharmaceutical care. CONCLUSIONS The inclusion of pharmacists in interdisciplinary care teams is recent and rising, strengthened by more significant pharmacist practice roles. Results will inform the processes required to successfully involve pharmacists and implement developed tools and procedures transposable to other care settings to improve patient care. CLINICALTRIAL NCT04889794
- 9 September 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessReorganizing pharmaceutical care in family medicine groups for seniors with or at risk of major neurocognitive disorders: protocol for a mixed-methods study (Preprint)
BACKGROUND The latest global figures show that 55 million persons lived with major neurocognitive disorders (MNCDs) worldwide in 2021. In Quebec, Canada, most of these seniors are cared for by family physicians in interdisciplinary primary care clinics such as family medicine groups (FMG). When a person suffers from a MNCD, taking potentially inappropriate medications or polypharmacy (five different medications or more) increases their vulnerability to serious adverse events. With the recent arrival of pharmacists working in FMGs and their expanded scope of practice and autonomy, new possibilities for optimizing seniors' pharmacotherapy are opening. OBJECTIVE This project aims to evaluate the impact of involving these pharmacists in the care trajectory of older adults living with MNCD, in an interdisciplinary collaboration with the FMG team, as well as home care nurses and physicians. Pharmacists will provide medication reviews, interventions, and recommendations to improve the pharmacotherapy and education provided to these patients and their caregivers. METHODS This 2-step mixed methods study will include a quasi-experimental controlled trial (step 1) and semi-structured interviews (step 2). Seniors undergoing cognitive assessment, recently diagnosed with MNCD or receiving care for this at home, will be identified and recruited in FMGs in two Quebec regions. FMGs implementing the intervention will involve pharmacists in these patients’ care trajectory. Training and regular mentoring will be offered to these FMGs, especially to pharmacists. In control FMGs, no FMG pharmacist will be involved with these patients, and usual care will be provided. RESULTS Medication use (including appropriateness) and burden, satisfaction of care received, and quality of life will be assessed at study beginning and after six months of follow-up and compared between groups. At the end of the intervention study, we will conduct semi-structured interviews with FMG care team members (pharmacists, nurses, physicians) who have experienced the intervention. We will ask about the feasibility of integrating the intervention into practice, their satisfaction with and their perception of the intervention impacts for seniors and their families. We will assess the effect of improved pharmaceutical care for seniors with or at risk of MNCDs through the involvement of FMG pharmacists and a reorganization of pharmaceutical care. CONCLUSIONS The inclusion of pharmacists in interdisciplinary care teams is recent and rising, strengthened by more significant pharmacist practice roles. Results will inform the processes required to successfully involve pharmacists and implement developed tools and procedures transposable to other care settings to improve patient care. CLINICALTRIAL NCT04889794